When is it safe to discontinue TKI therapy in people with chronic myeloid leukemia?
Some patients reach a point where ongoing TKI therapy can cause more harm than good. New data can simplify the decision to discontinue treatment.
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater Risk
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater Risk// // In January 2015, Advera Health released a Drug Safety Monitor analysis comparing the safety of then newly approved Hepatitis C drugs Viekira Pak to Harvoni and Solvaldi (hereafter just Harvoni). Our analysts concluded, …both Harvoni and Sovaldi appear […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Non-Negotiable Cost of Drugs
In the past several months the “war on drugs” has intensified. But the war is no longer defined as an offensive against illegal narcotics, but one against pharmaceutical companies and the increasing costs of specialty drugs. With the donkeys, elephants, and other political animals gearing up for the 2016 electoral stampede, it seems that each […]
How do we know when medical treatments will do more harm than good?
We all know that most medical treatments have potential side effects, some more than others of course. But it can be difficult to break down and conceptualize the numbers as far as determining if certain therapies will do more harm than good. That’s where Number Needed to Treat, or N.N.T. and Number Needed to Harm N.N.H. […]